Stemmer Imaging AG Logo

Stemmer Imaging AG

S9I.DE

(2.2)
Stock Price

48,30 EUR

17.58% ROA

15.7% ROE

26.01x PER

Market Cap.

313.300.000,00 EUR

0.74% DER

5.6% Yield

9.54% NPM

Stemmer Imaging AG Stock Analysis

Stemmer Imaging AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Stemmer Imaging AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (24.54%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (3%), which means it has a small amount of debt compared to the ownership it holds

4 PBV

The stock's PBV ratio (2.49x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past three years, consistently delivering higher payouts to shareholders.

6 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-72) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Stemmer Imaging AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Stemmer Imaging AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Stemmer Imaging AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Stemmer Imaging AG Revenue
Year Revenue Growth
2013 64.975.857
2014 75.727.959 14.2%
2015 83.601.738 9.42%
2016 88.304.143 5.33%
2017 100.634.000 12.25%
2018 108.966.000 7.65%
2019 124.674.000 12.6%
2020 105.181.000 -18.53%
2021 130.115.000 19.16%
2022 155.370.000 16.25%
2023 138.392.000 -12.27%
2023 146.293.000 5.4%
2024 123.200.000 -18.74%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Stemmer Imaging AG Research and Development Expenses
Year Research and Development Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 710.000 100%
2018 0 0%
2019 1.440.000 100%
2020 1.370.000 -5.11%
2021 1.710.000 19.88%
2022 1.660.000 -3.01%
2023 0 0%
2023 1.270.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Stemmer Imaging AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 3.744.000 100%
2019 0 0%
2020 3.289.000 100%
2021 3.093.000 -6.34%
2022 4.643.000 33.38%
2023 0 0%
2023 4.450.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Stemmer Imaging AG EBITDA
Year EBITDA Growth
2013 4.978.354
2014 5.468.636 8.97%
2015 6.052.447 9.65%
2016 6.049.484 -0.05%
2017 6.472.000 6.53%
2018 7.130.000 9.23%
2019 7.656.000 6.87%
2020 7.801.000 1.86%
2021 18.232.000 57.21%
2022 28.548.000 36.14%
2023 22.780.000 -25.32%
2023 27.820.000 18.12%
2024 20.032.000 -38.88%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Stemmer Imaging AG Gross Profit
Year Gross Profit Growth
2013 22.066.219
2014 26.008.417 15.16%
2015 29.405.500 11.55%
2016 30.798.434 4.52%
2017 36.644.000 15.95%
2018 38.787.000 5.53%
2019 14.044.000 -176.18%
2020 38.681.000 63.69%
2021 50.415.000 23.27%
2022 58.356.000 13.61%
2023 53.096.000 -9.91%
2023 29.199.000 -81.84%
2024 49.224.000 40.68%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Stemmer Imaging AG Net Profit
Year Net Profit Growth
2013 2.858.399
2014 1.810.420 -57.89%
2015 2.182.635 17.05%
2016 2.802.475 22.12%
2017 2.935.000 4.52%
2018 4.382.000 33.02%
2019 -2.802.000 256.39%
2020 -3.323.000 15.68%
2021 10.450.000 131.8%
2022 17.973.000 41.86%
2023 10.808.000 -66.29%
2023 15.730.000 31.29%
2024 11.492.000 -36.88%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Stemmer Imaging AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 1 0%
2019 0 0%
2020 -1 0%
2021 2 100%
2022 3 50%
2023 2 -100%
2023 2 50%
2024 2 -100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Stemmer Imaging AG Free Cashflow
Year Free Cashflow Growth
2013 4.254.999
2014 814.000 -422.73%
2015 3.718.000 78.11%
2016 3.668.000 -1.36%
2017 2.941.000 -24.72%
2018 3.637.000 19.14%
2019 -153.000 2477.12%
2020 10.458.000 101.46%
2021 7.720.000 -35.47%
2022 14.726.000 47.58%
2023 19.082.000 22.83%
2023 7.233.000 -163.82%
2024 5.894.000 -22.72%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Stemmer Imaging AG Operating Cashflow
Year Operating Cashflow Growth
2013 4.795.999
2014 1.618.000 -196.42%
2015 5.035.000 67.86%
2016 5.151.000 2.25%
2017 3.345.000 -53.99%
2018 4.938.000 32.26%
2019 1.852.000 -166.63%
2020 10.883.000 82.98%
2021 7.969.000 -36.57%
2022 15.895.000 49.86%
2023 20.136.000 21.06%
2023 7.558.000 -166.42%
2024 6.096.000 -23.98%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Stemmer Imaging AG Capital Expenditure
Year Capital Expenditure Growth
2013 541.000
2014 804.000 32.71%
2015 1.317.000 38.95%
2016 1.483.000 11.19%
2017 404.000 -267.08%
2018 1.301.000 68.95%
2019 2.005.000 35.11%
2020 425.000 -371.76%
2021 249.000 -70.68%
2022 1.169.000 78.7%
2023 1.054.000 -10.91%
2023 325.000 -224.31%
2024 202.000 -60.89%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Stemmer Imaging AG Equity
Year Equity Growth
2013 20.585.809
2014 23.309.851 11.69%
2015 24.972.498 6.66%
2016 14.619.378 -70.82%
2017 68.437.000 78.64%
2018 71.616.000 4.44%
2019 67.213.000 -6.55%
2020 64.079.000 -4.89%
2021 71.368.000 10.21%
2022 84.079.000 15.12%
2023 80.485.000 -4.47%
2023 75.980.000 -5.93%
2024 67.895.000 -11.91%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Stemmer Imaging AG Assets
Year Assets Growth
2013 31.059.011
2014 32.443.455 4.27%
2015 34.345.009 5.54%
2016 28.708.229 -19.63%
2017 82.905.000 65.37%
2018 87.454.000 5.2%
2019 100.936.000 13.36%
2020 96.684.000 -4.4%
2021 103.576.000 6.65%
2022 120.555.000 14.08%
2023 105.916.000 -13.82%
2023 105.778.000 -0.13%
2024 94.739.000 -11.65%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Stemmer Imaging AG Liabilities
Year Liabilities Growth
2013 8.072.081
2014 9.133.603 11.62%
2015 9.372.509 2.55%
2016 14.088.851 33.48%
2017 14.468.000 2.62%
2018 15.838.000 8.65%
2019 33.723.000 53.04%
2020 32.605.000 -3.43%
2021 32.208.000 -1.23%
2022 36.476.000 11.7%
2023 25.431.000 -43.43%
2023 29.798.000 14.66%
2024 26.844.000 -11%

Stemmer Imaging AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
19.42
Net Income per Share
1.85
Price to Earning Ratio
26.01x
Price To Sales Ratio
2.48x
POCF Ratio
11.42
PFCF Ratio
11.74
Price to Book Ratio
4.61
EV to Sales
2.25
EV Over EBITDA
12.97
EV to Operating CashFlow
10.34
EV to FreeCashFlow
10.62
Earnings Yield
0.04
FreeCashFlow Yield
0.09
Market Cap
0,31 Bil.
Enterprise Value
0,28 Bil.
Graham Number
20.87
Graham NetNet
3.71

Income Statement Metrics

Net Income per Share
1.85
Income Quality
2.28
ROE
0.16
Return On Assets
0.13
Return On Capital Employed
0.23
Net Income per EBT
0.72
EBT Per Ebit
1
Ebit per Revenue
0.13
Effective Tax Rate
0.28

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.3
Operating Profit Margin
0.13
Pretax Profit Margin
0.13
Net Profit Margin
0.1

Dividends

Dividend Yield
0.06
Dividend Yield %
5.6
Payout Ratio
1.51
Dividend Per Share
2.7

Operating Metrics

Operating Cashflow per Share
4.22
Free CashFlow per Share
4.11
Capex to Operating CashFlow
0.03
Capex to Revenue
0.01
Capex to Depreciation
0.15
Return on Invested Capital
0.18
Return on Tangible Assets
0.18
Days Sales Outstanding
58.71
Days Payables Outstanding
54.37
Days of Inventory on Hand
44.22
Receivables Turnover
6.22
Payables Turnover
6.71
Inventory Turnover
8.25
Capex per Share
0.11

Balance Sheet

Cash per Share
4,67
Book Value per Share
10,45
Tangible Book Value per Share
6.41
Shareholders Equity per Share
10.45
Interest Debt per Share
0.11
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
-1.36
Current Ratio
2.99
Tangible Asset Value
0,04 Bil.
Net Current Asset Value
0,04 Bil.
Invested Capital
73002000
Working Capital
0,04 Bil.
Intangibles to Total Assets
0.28
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
11061000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Stemmer Imaging AG Dividends
Year Dividends Growth
2021 1
2022 1 0%
2023 2 100%
2024 3 0%

Stemmer Imaging AG Profile

About Stemmer Imaging AG

Stemmer Imaging AG provides machine vision technology for industry and non-industry applications worldwide. The company offers machine vision systems, such as 2D and 3D smart vision, application specific, hyperspectral, surface inspection, open architecture vision, and sequence recording systems; illumination products, including LED illumination products, diode lasers, cold light sources and high-frequency illumination products, and accessories for illumination; and optics consisting of zoom, fixed focus, telecentric measuring, macro and modular, motorized, line scan camera, infrared, UV, 3D, 360 degree, and multimagnification lenses, as well as accessories for lenses. It also provides area and line scan, 3D, smart, high speed recording, and spectral cameras, as well as contact image sensors and ID readers, and accessories for cameras; and CameraLink, GigE, CoaXPress, USB, FireWire, fibre optic, and analogue cables. In addition, the company offers CameraLink, CameraLink HS-Link, CoaXPress, GigE, DVI, LVDS, analogue, and FireWire input products, as well as accessories for image acquisition; IP streaming and video decoders/encoders; computers, such as industrial, compact, and embedded PC systems; and various machine vision software products. Further, it provides feasibility testing, training, sale or returns and loans, repairs, and custom cables services. The company serves the automotive, defense, security and aerospace, electronics, semiconductor and solar, factory automation, food and beverage, medical imaging, pharmaceutical, print and packaging, scientific research, sports, entertainment and broadcast, test and measurement, traffic, and rail and transport markets. Stemmer Imaging AG was founded in 1987 and is headquartered in Puchheim, Germany. Stemmer Imaging AG is a subsidiary of Primepulse SE.

CEO
Mr. Arne E. Dehn
Employee
271
Address
Gutenbergstrasse 9-13
Puchheim, 82178

Stemmer Imaging AG Executives & BODs

Stemmer Imaging AG Executives & BODs
# Name Age
1 Mr. Baptiste Guldner
Managing Director of Cluster Western Europe
70
2 Mr. Arne E. Dehn
Chairman of Management Board & Chief Executive Officer
70
3 Peter Trollsas
Managing Director of Sweden & Finland
70
4 Mr. Michael Bulter
Chief Financial Officer
70
5 Daniele Cosentino
Director of Marketing
70
6 Pedro Duran
Managing Director of Cluster Southern Europe & LATAM
70
7 Mr. Uwe Kemm
Chief Operating Officer & Member of the Executive Board
70

Stemmer Imaging AG Competitors

Dermapharm Holding SE Logo
Dermapharm Holding SE

DMP.DE

(2.8)
Aumann AG Logo
Aumann AG

AAG.DE

(2.2)
GFT Technologies SE Logo
GFT Technologies SE

GFT.DE

(3.0)
SÜSS MicroTec SE Logo
SÜSS MicroTec SE

SMHN.DE

(2.5)